indazoles has been researched along with Body Weight in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.13) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, K; Baurain, JF; Calvert, PM; Denys, H; Follana, P; Gaba, L; Ghamande, SA; González-Martín, A; Graybill, WS; Guerra, EM; Gupta, D; Korach, J; Li, Y; Malinowska, IA; Mirza, MR; Monk, BJ; O'Malley, DM; Pisano, C; Prendergast, E; Rose, PG; Stephanie Yap, OW | 1 |
| Cefalu, M; Guo, A; Ho, TH; Janssen, P; Justice, C; Kempton, A; Makara, M; Smith, SA | 1 |
| Berek, JS; Berton-Rigaud, D; Colombo, N; Ellard, S; Ghatage, P; Gonzalez-Martin, A; Guo, W; Hazard, S; Ledermann, J; Lesoin, A; Madry, R; Mahner, S; Matulonis, UA; Mirza, MR; Peen, U; Pineda, M; Redondo, A; Reinthaller, A; Rosengarten, O; Sehouli, J; Vergote, I | 1 |
| Cacanyiova, S; Kristek, F; Malekova, M; Ondrias, K | 1 |
| Amantea, MA; Brennan, M; Garrett, M; Hee, B; Pithavala, YK; Poland, B | 1 |
| Davis, JM; Guglielmotti, A; McClellan, JL; Murphy, EA; Steiner, JL | 1 |
| Cheruvallath, Z; Dougan, DR; Erikson, P; Farrell, P; Feng, J; Holub, C; Komandla, M; Larson, C; Lawson, JD; McBride, C; Miura, J; Plonowski, A; Tang, M; Ton-Nu, T; Vanderpool, D; Wu, Y | 1 |
| Kalinic, L; Katalenic, D; Makarevic, J; Marijic, VF; Radacic, M; Stojkovic, R | 1 |
| Cacanyiova, S; Gerova, M; Kristek, F | 1 |
| Baluchnejadmojarad, T; Roghani, M | 1 |
| Kompella, UB; Rao, VR; Scheinman, RI; Thakur, A | 1 |
| Lazzari, P; Mastinu, A; Pani, L; Pinna, GA; Pira, M | 1 |
| Bezin, L; Corcoran, GB; Groc, L; Jackson Hunter, T; Jiang, H; Koubi, D; Levine, RA | 1 |
| Gerstberger, R; Horowitz, M; Schwimmer, H | 2 |
| Hayashi, A; Kimura, Y; Miyata, K; Sasamata, M; Sonoda, R; Suzuki, M; Takasu, T | 1 |
| Allard, J; Arnal, JF; Escourrou, G; Gamé, X; Gourdy, P; Malavaud, B; Rischmann, P; Tack, I | 1 |
| Attardi, B; Chakrasali, R; Georg, GI; Hild, SA; Jakkaraj, SR; Tash, JS | 1 |
| Bardin, CW; Gunsalus, GL; Lobl, TJ; Musto, NA | 1 |
| Caputo, A | 1 |
| Barcellona, PS; Campana, A; Cioli, V; Heywood, R; James, RW | 1 |
| Ansari, AS; Kumar, Y; Lohiya, NK; Srivastava, S | 1 |
| Bespalov, AY; Dravolina, OA; Medvedev, IO | 1 |
| Azuma, H; Goto, M; Hamasaki, H; Masuda, H; Sato, J; Sugimoto, A; Tamaoki, S; Yamashita, H | 1 |
| Mizuno, M; Nabeshima, T; Nawa, H; Olariu, A; Yamada, K | 1 |
| Cheng, CY; Grima, J; Silvestrini, B | 1 |
| Abraham, R; Coulston, F; Dougherty, WJ; LeFevre, R; Silvestrini, B | 1 |
| Glazer, EA; McFarland, JW; Newcomb, DM; Ricketts, AP; Shively, JE | 1 |
| Berger, MR; Keppler, BK; Seelig, MH | 1 |
| Ansari, AS; Lohiya, NK; Scorza Barcellona, P | 1 |
| Boranić, M; Gajsak, V; Jercić, J; Lelieveld, P; Mihalić, H; Radacić, M; Skarić, D; Skarić, V | 1 |
2 trial(s) available for indazoles and Body Weight
| Article | Year |
|---|---|
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Topics: Body Weight; Carcinoma, Ovarian Epithelial; Female; Humans; Indazoles; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Prospective Studies | 2023 |
Safety and dose modification for patients receiving niraparib.
Topics: Administration, Oral; Adult; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Incidence; Indazoles; Maintenance Chemotherapy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platelet Count; Poly(ADP-ribose) Polymerase Inhibitors; Progression-Free Survival; Retrospective Studies; Risk Factors; Thrombocytopenia | 2018 |
29 other study(ies) available for indazoles and Body Weight
| Article | Year |
|---|---|
Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model.
Topics: Angiogenesis Inhibitors; Animals; Arterial Pressure; Body Weight; Carcinoma, Renal Cell; Cardiac Output; Disease Models, Animal; Echocardiography; Electrocardiography; Heart; Hypertension; Indazoles; Kidney; Kidney Neoplasms; Mice; Myocardium; Pyrimidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sulfonamides; Vascular Endothelial Growth Factor A | 2018 |
Blood pressure-independent hypotrophy of the heart, kidneys and conduit arteries after 7-nitroindazole administration to Wistar rats from the prenatal period to adulthood.
Topics: Animals; Aorta, Thoracic; Arterial Pressure; Body Weight; Carotid Arteries; Female; Heart; Indazoles; Kidney; Myocardium; Nitric Oxide Synthase Type I; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar | 2013 |
Population pharmacokinetic analysis of axitinib in healthy volunteers.
Topics: Adult; Angiogenesis Inhibitors; Aryl Hydrocarbon Hydroxylases; Axitinib; Biotransformation; Body Weight; Clinical Trials, Phase I as Topic; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Female; Genotype; Glucuronosyltransferase; Healthy Volunteers; Humans; Imidazoles; Indazoles; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Pharmacogenetics; Phenotype; Protein Kinase Inhibitors; Young Adult | 2014 |
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Topics: Animals; Antigens, Polyomavirus Transforming; Biomarkers; Body Weight; Carcinogenesis; Chemokine CCL2; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Indazoles; Inflammation Mediators; Interleukin-6; Macrophages; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Organ Size; Propionates; RNA, Messenger; Spleen; Tumor Burden; Tumor Necrosis Factor-alpha | 2014 |
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.
Topics: Administration, Oral; Aminopeptidases; Animals; Body Weight; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Glycoproteins; Humans; Indazoles; Methionyl Aminopeptidases; Mice; Mice, Obese; Models, Molecular; Molecular Structure; Obesity; Structure-Activity Relationship | 2016 |
Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Cisplatin; Indazoles; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Pyrazolones | 2008 |
Hypotrophic effect of long-term neuronal NO-synthase inhibition on heart and conduit arteries of the Wistar rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Carotid Arteries; Coronary Vessels; Dose-Response Relationship, Drug; In Vitro Techniques; Indazoles; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type I; Organ Size; Rats; Rats, Wistar; Time Factors | 2009 |
Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress.
Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Experimental; Hippocampus; Indazoles; Learning Disabilities; Male; Malondialdehyde; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitrites; Oxidative Stress; Rats; Rats, Wistar | 2011 |
Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
Topics: Administration, Ophthalmic; Animals; Blood Glucose; Blood Proteins; Blood-Retinal Barrier; Body Weight; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Indazoles; Leukocytes; Leukostasis; Macular Edema; Male; Molecular Targeted Therapy; Ophthalmic Solutions; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Inbred BN; Sulfonamides; Time Factors; Vitreous Body | 2011 |
NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Topics: Analysis of Variance; Animals; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Body Weight; Brain-Derived Neurotrophic Factor; Cannabinoid Receptor Antagonists; Cholesterol; Dietary Fats; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypothalamus; Indazoles; Intra-Abdominal Fat; Liver; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin Plasma Membrane Transport Proteins; Thiophenes; Transaminases; Triglycerides | 2012 |
Nitric oxide synthase inhibition during development: effect on apoptotic death of dopamine neurons.
Topics: Animals; Animals, Newborn; Apoptosis; Body Weight; Dopamine; Enzyme Inhibitors; Female; Immunohistochemistry; In Situ Nick-End Labeling; Indazoles; NADPH Dehydrogenase; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pregnancy; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Nitric oxide and angiotensin II: neuromodulation of thermoregulation during combined heat and hypohydration stress.
Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Body Temperature; Body Temperature Regulation; Body Weight; Cell Membrane; Cell Nucleus; Dehydration; Drug Interactions; Enzyme Inhibitors; Heat Stress Disorders; Indazoles; Injections, Intraventricular; Losartan; Male; Nitric Oxide; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salivation; Vasodilation | 2004 |
Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats.
Topics: Aminopyridines; Animals; Anti-Obesity Agents; Blood Glucose; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Eating; Energy Intake; Indazoles; Indoles; Insulin; Lipids; Male; Obesity; Rats; Rats, Zucker; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Time Factors; Weight Gain | 2004 |
Heat acclimation affects the neuromodulatory role of AngII and nitric oxide during combined heat and hypohydration stress.
Topics: Acclimatization; Analysis of Variance; Angiotensin II; Animals; Behavior, Animal; Body Weight; Drug Combinations; Enzyme Inhibitors; Gene Expression Regulation; Hot Temperature; Indazoles; Injections, Intraventricular; Male; Models, Biological; Nitric Oxide; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Salivation; Stress, Physiological; Vasodilation; Water Deprivation | 2004 |
Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression.
Topics: Animals; Blotting, Western; Body Weight; Estradiol; Estrus; Female; Indazoles; Mice; Mice, Inbred C57BL; Muscle Tonus; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Organ Size; Ovariectomy; Urethra; Urinary Bladder; Urination | 2008 |
A novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose.
Topics: Administration, Oral; Animals; Body Weight; Female; Fertility; Follicle Stimulating Hormone; Genitalia, Male; Hydrazines; Indazoles; Inhibins; Male; Organ Size; Pregnancy; Rats; Rats, Long-Evans; Spermatogenesis; Spermatogenesis-Blocking Agents; Testis; Time Factors | 2008 |
Effects of Lonidamine (AF 1890) and its analogues on follicle-stimulating hormone, luteinizing hormone, testosterone and rat androgen binding protein concentrations in the rat and rhesus monkey.
Topics: Androgen-Binding Protein; Animals; Antispermatogenic Agents; Body Weight; Carrier Proteins; Follicle Stimulating Hormone; Indazoles; Luteinizing Hormone; Macaca mulatta; Male; Organ Size; Pyrazoles; Rats; Sperm Count; Testis; Testosterone; Time Factors | 1981 |
Preliminary results in some tumor systems with indazolecarboxylic acids.
Topics: Animals; Body Weight; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Germ Cells; Glycolysis; Indazoles; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrazoles; Time Factors | 1981 |
Toxicological studies on 1-substituted-indazole-3-carboxylic acids.
Topics: Animals; Antispermatogenic Agents; Body Weight; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Indazoles; Kidney; Lethal Dose 50; Macaca mulatta; Male; Mice; Organ Size; Pituitary Gland; Prostate; Pyrazoles; Rats; Semen; Testis | 1981 |
Long-term sequelae of tolnidamine on male reproduction and general body metabolism in rabbits.
Topics: Animals; Antispermatogenic Agents; Body Weight; Dose-Response Relationship, Drug; Fertility; Hematologic Tests; Indazoles; Libido; Male; Semen; Testis; Testosterone | 1998 |
Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats.
Topics: Analgesics, Opioid; Animals; Body Weight; Discrimination Learning; Drug Interactions; Enzyme Inhibitors; Indazoles; Male; Maze Learning; Morphine; Naloxone; Narcotic Antagonists; Nitric Oxide Synthase; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Substance-Related Disorders | 1999 |
ATZ1993, an orally active and novel nonpeptide antagonist for endothelin receptors and inhibition of intimal hyperplasia after balloon denudation of the rabbit carotid artery.
Topics: Administration, Oral; Angioplasty, Balloon; Animals; Blood Pressure; Body Weight; Carotid Artery Injuries; Carotid Artery, Common; Endothelin Receptor Antagonists; Endothelin-1; Heart Rate; Humans; Hyperplasia; Indazoles; Male; Muscle, Smooth, Vascular; Rabbits; Receptors, Endothelin; Swine; Tunica Intima | 1999 |
Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats.
Topics: Analysis of Variance; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Eating; Frontal Lobe; Hippocampus; Indazoles; Injections, Intraventricular; Male; Maze Learning; Motor Activity; Nitric Oxide Synthase; Oligonucleotides, Antisense; Rats; Rats, Wistar; Retention, Psychology; RNA, Messenger; Spatial Behavior | 2000 |
Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide.
Topics: Animals; Antispermatogenic Agents; Body Weight; Brain; Contraceptive Agents, Male; Epididymis; Female; Fertility; Follicle Stimulating Hormone; Hydrazines; Indazoles; Kidney; Litter Size; Liver; Luteinizing Hormone; Male; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testis; Testosterone | 2001 |
Reversible inhibition of spermatogenesis in rats and monkeys with a new class of indazol-carboxylic acids.
Topics: Animals; Antispermatogenic Agents; Body Weight; Dose-Response Relationship, Drug; Haplorhini; Indazoles; Macaca mulatta; Male; Organ Size; Pyrazoles; Rats; Seminiferous Epithelium; Sertoli Cells; Spermatocytes; Spermatogonia; Spermatozoa; Testis | 1975 |
Anticoccidial activities of 7-bromo-N-(2-imidazolidinylidene)-1H-indazol-6-amine and other alpha 2 adrenergic agonists.
Topics: Adrenergic alpha-Agonists; Animals; Body Weight; Chickens; Clonidine; Coccidiosis; Coccidiostats; Eimeria tenella; Imidazoles; Indazoles; Male; Poultry Diseases | 1992 |
Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Imidazoles; Indazoles; Male; Organometallic Compounds; Rats; Rats, Inbred Strains; Ruthenium | 1992 |
Antispermatogenic effects of tolnidamine in langur (Presbytis entellus).
Topics: Acid Phosphatase; Animals; Antispermatogenic Agents; Blood Chemical Analysis; Body Weight; Cercopithecidae; Fructose; Glycerylphosphorylcholine; Indazoles; L-Lactate Dehydrogenase; Leydig Cells; Libido; Magnesium; Male; Semen; Seminiferous Tubules; Sertoli Cells; Sperm Count; Sperm Motility; Spermatozoa; Testosterone | 1991 |
Reduction of cis-dichlorodiammineplatinum(II) caused nephrotoxicity by indazolone carboxylic acid.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Cell Division; Cell Survival; Cisplatin; Indazoles; Kidney; Kidney Diseases; Leukemia L1210; Male; Mice; Mice, Inbred CBA; Necrosis; Pyrazoles | 1987 |